Figure 5. Changes in total cfRNA vs. outcome in response to various therapies across different tumor types. The bars represent analyses of 154 BC, 84 CRC, 135 NSCLC patient samples. BC: Breast cancer; CRC: colorectal cancer; NSCLC: non-small cell lung cancer.
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.
By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection. See our privacy policy for more information on the use of your personal data.
